We are international
Donate
publications TEXT SIZE   
meeting highlights    back

A Phase II Study of Velcade, Doxil, and Thalidomide (VDT) in Relapsed/Refractory Myeloma
By Asher A. Chanan-Khan, MD
12.18.06

Be the first to comment

 related articles